Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE897.4032.3 (+3.73 %)

PREV CLOSE ( ) 865.10

OPEN PRICE ( ) 860.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16603

TODAY'S LOW / HIGH ( )844.00 908.35

52 WK LOW / HIGH ( )285.8 950

NSE896.6035.55 (+4.13 %)

PREV CLOSE( ) 861.05

OPEN PRICE ( ) 833.60

BID PRICE (QTY) 896.60 (68)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 94779

TODAY'S LOW / HIGH( ) 831.10 904.10

52 WK LOW / HIGH ( )285.7 944.75

Chairman	Pawan Chaudhary
Managing Director	Pawan Chaudhary
Company Secretary	Neha
Joint Managing Director	Manu Chaudhary
Deputy Managing Director	Peeyush Jain
Non Executive Independent Director	Navdeep Sud Savita Gupta NPS Monga Jagdish Chander Sharma Anil Kumar
Whole Time Director	Ashutosh Jain Akshansh Chaudhary

Incorporation Year : 1989

Registered Office :

Address : S. C. O. 857, C. No. 10,2nd Floor,N A C Manimajra Chandigarh,
Union Territory-160101 .

Phone : 0172-2561244/5577

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE